SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

SEC Comment Letter for Park Dental Partners, (PARK) — Nov 14, 2025

Park Dental Partners, Inc.
Date: Nov. 14, 2025 · CIK: 0002069604 · Accession: 0000000000-25-010785

Financial Reporting Capital Structure Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-290001

Date
November 14, 2025
Author
Peter G. Swenson
Form
UPLOAD
Company
Park Dental Partners, Inc.

Letter

November 14, 2025 Peter G. Swenson President, Chief Executive Officer and Chairman Park Dental Partners, Inc. 2200 Country Road C West, Suite 2210 Roseville, MN 55113 Re:Park Dental Partners, Inc. Amendment No. 1 to Registration Statement on Form S-1 Filed September 24, 2025 File No. 333-290001 Dear Peter G. Swenson: We have reviewed your amended registration statement and have the following comment. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe a comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to this letter, we may have additional comments. Unless we note otherwise, any references to prior comments are to comments in our September 17, 2025 letter. Amendment No. 1 to Registration Statement on Form S-1 Filed September 24, 2025 Capitalization, page 44 1.Please clearly describe how you arrived at each pro forma 2025 and proforma as adjusted amount. The paragraph above the capitalization table indicates that pro forma 2025 amounts only give effect to the vesting of 25% of the outstanding restricted common stock; however, it appears that the offering may also be reflected in these amounts. Please revise your disclosures as necessary. Please also correspondingly revise your disclosures on page 19 as necessary related to the pro forma balance sheet amounts presented.

November 14, 2025 Page 2 Please contact Nudrat Salik at 202-551-3692 or Terence O'Brien at 202-551-3355 if you have questions regarding comments on the financial statements and related matters. Please contact Nicholas O'Leary at 202-551-4451 or Katherine Bagley at 202-551- 2545 with any other questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc:Philip T. Colton, Esq.

Show Raw Text
November 14, 2025
Peter G. Swenson
President, Chief Executive Officer and Chairman
Park Dental Partners, Inc.
2200 Country Road C West, Suite 2210
Roseville, MN 55113
Re:Park Dental Partners, Inc.
Amendment No. 1 to
Registration Statement on Form S-1
Filed September 24, 2025
File No. 333-290001
Dear Peter G. Swenson:
            We have reviewed your amended registration statement and have the following
comment.
            Please respond to this letter by amending your registration statement and providing
the requested information. If you do not believe a comment applies to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
            After reviewing any amendment to your registration statement and the information
you provide in response to this letter, we may have additional comments. Unless we note
otherwise, any references to prior comments are to comments in our September 17,
2025 letter.
Amendment No. 1 to Registration Statement on Form S-1 Filed September 24, 2025
Capitalization, page 44
1.Please clearly describe how you arrived at each pro forma 2025 and proforma as
adjusted amount. The paragraph above the capitalization table indicates that pro forma
2025 amounts only give effect to the vesting of 25% of the outstanding restricted
common stock; however, it appears that the offering may also be reflected in these
amounts. Please revise your disclosures as necessary. Please also correspondingly
revise your disclosures on page 19 as necessary related to the pro forma balance sheet
amounts presented.

November 14, 2025
Page 2
            Please contact Nudrat Salik at 202-551-3692 or Terence O'Brien at 202-551-3355 if
you have questions regarding comments on the financial statements and related
matters. Please contact Nicholas O'Leary at 202-551-4451 or Katherine Bagley at 202-551-
2545 with any other questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc:Philip T. Colton, Esq.